Guests: Dr. Shawn Hingtgen, Assistant Professor, Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy; Dr. Matthew Ewend, Chair, Department of Neurological Surgery, UNC, Group Leader, NeuroOncology, UNC Lineberger Comprehensive Cancer Center
Topics: Stem cell therapies for brain cancer (glioblastoma multiforme), mouse models, real-time non-invasive imaging, clinical perspectives on brain tumor treatment

Hingtgen Lab

Shawn’s faculty page

Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma, (abstract), Nature Communications, February, 2016

“Meet Matthew Ewend, MD”

Scicast: Early Tumour Response from Stereotactic Radiosurgery Predicts Outcome

Click to Download: Radio In Vivo March 30, 2016

Dr. Shawn Hingtgen

Dr. Matthew Ewend